P. Lehn

S. Nedellec, C. Pichon, P. Midoux, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

In vivo biodistribution and oxygenation potential of a new generation of oxygen carrier.

P. Opolon, M. Rousselot, T. Montier, 2014, Journal of biotechnology.

Glycosidase active site mutations in human α-L-iduronidase

B. Henrissat, J. Mornon, D. Brooks, 2001 .

Aminoglycoside-Derived Cationic Lipids for Gene Transfection: Synthesis of Kanamycin A Derivatives

J. Lehn, M. Sainlos, P. Lehn, 2003 .

Human glucocerebrosidase: heterologous expression of active site mutants in murine null cells.

E. Ginns, B. Henrissat, C. Bauvy, 2000, Glycobiology.

Modular Construction of Fluorescent Lipophosphoramidates by Click Chemistry

P. Midoux, H. Couthon-Gourvès, P. Jaffrès, 2011 .

Molecular models of the open and closed states of the whole human CFTR protein

Isabelle Callebaut, Jean-Paul Mornon, J. Mornon, 2009, Cellular and Molecular Life Sciences.

Arsonium‐Containing Lipophosphoramides, Poly‐Functional Nano‐Carriers for Simultaneous Antibacterial Action and Eukaryotic Cell Transfection

C. Férec, Aurore Fraix, T. Montier, 2013, Advanced healthcare materials.

Atomic model of human cystic fibrosis transmembrane conductance regulator: Membrane-spanning domains and coupling interfaces

J. Mornon, I. Callebaut, P. Lehn, 2008, Cellular and Molecular Life Sciences.

Nucleotide-binding domains of human cystic fibrosis transmembrane conductance regulator: detailed sequence analysis and three-dimensional modeling of the heterodimer

J. Mornon, I. Callebaut, P. Lehn, 2003, Cellular and Molecular Life Sciences CMLS.

Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.

P. Loyer, C. Pichon, P. Midoux, 2015, Biotechnology journal.

The ARRIVE guidelines, a welcome improvement to standards for reporting animal research

Kay E. Davies, O. Danos, P. Lehn, 2010, The journal of gene medicine.

The Early History of Nanocarriers as Drug Delivery Systems

T. Montier, P. Guégan, H. Chéradame, 2015 .

Lipothiophosphoramidates for gene delivery: critical role of the cationic polar headgroup.

Aurore Fraix, T. Montier, T. Le Gall, 2012, Organic & biomolecular chemistry.

Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure.

T. Montier, T. Le Gall, P. Jaffrès, 2015, Biomaterials.

Cationic Trialkylphosphates: Synthesis and Transfection Efficacies Compared to Phosphoramidate Analogues

T. Montier, T. L. Gall, P. Jaffrès, 2014 .

The gene transfection properties of a lipophosphoramidate derivative with two phytanyl chains.

Aurore Fraix, T. Montier, T. Le Gall, 2012, Biomaterials.

A novel cationic lipophosphoramide with diunsaturated lipid chains: synthesis, physicochemical properties, and transfection activities.

D. Loizeau, P. Delépine, T. Montier, 2010, Journal of medicinal chemistry.

Efficient gene transfection by bisguanylated diacetylene lipid formulations.

J. Lehn, P. Lehn, N. Oudrhiri, 2001, Biochemical and biophysical research communications.

Full-open and closed CFTR channels, with lateral tunnels from the cytoplasm and an alternative position of the F508 region, as revealed by molecular dynamics

Slavica Jonic, Brice Hoffmann, Isabelle Callebaut, 2014, Cellular and Molecular Life Sciences.

Molecular modelling and molecular dynamics of CFTR

Brice Hoffmann, Isabelle Callebaut, Jean-Paul Mornon, 2016, Cellular and Molecular Life Sciences.

Active-site motifs of lysosomal acid hydrolases: invariant features of clan GH-A glycosyl hydrolases deduced from hydrophobic cluster analysis.

B. Henrissat, J. Mornon, I. Callebaut, 1997, Glycobiology.

Nucleotide binding domains of human CFTR: a structural classification of critical residues and disease-causing mutations.

C. Férec, J. Mornon, I. Callebaut, 2005, Cellular and Molecular Life Sciences CMLS.

Cationic Lipids Based on Phosphonate and Phosphoramidate Chemistry: Synthesis and Application to Gene Therapy

C. Férec, P. Laurent, C. Pichon, 2008 .

Synthetic Phospholipids for pDNA Delivery and Antibacterial Action

T. Montier, T. Le Gall, H. Couthon-Gourvès, 2015 .

Trimethylarsonium-Based Cationic Phospholipids for Gene Delivery

P. Midoux, T. Montier, T. Le Gall, 2013 .

Nonionic amphiphilic block copolymers promote gene transfer to the lung.

D. Escande, H. Pollard, B. Pitard, 2005, Human gene therapy.

Folate PEGylated archaeal lipids: cell targeting and drug delivery.

T. Montier, L. Lemiègre, T. Benvegnu, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Atomic model of human cystic fibrosis transmembrane conductance regulator: Membrane-spanning domains and coupling interfaces

J. Mornon, I. Callebaut, P. Lehn, 2008, Cellular and Molecular Life Sciences.

Silver-Phosphonate Based Metal Organic Frameworks: Synthesis and Antibacterial Action

T. Montier, T. Le Gall, H. Couthon-Gourvès, 2013 .

Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure.

T. Montier, T. Le Gall, P. Jaffrès, 2015, Biomaterials.

Combining keratinocyte growth factor transfection into the airways and tracheal occlusion in a fetal sheep model of congenital diaphragmatic hernia

D. Luton, J. Oury, J. Lehn, 2010, The journal of gene medicine.

Lipothiophosphoramidates for gene delivery: critical role of the cationic polar headgroup.

Aurore Fraix, T. Montier, T. Le Gall, 2012, Organic & biomolecular chemistry.